Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness
1 other identifier
interventional
32
1 country
1
Brief Summary
Burnout shares symptoms with anxiety and depression. While there is no single intervention for burnout, there are validated interventions (which are amenable to virtual reality (VR)) for anxiety and depression. UMassMemorial data from the Professional Well-Being Academic Consortium show that MD burnout and distress has increased since 2020. The investigators believe providing clinicians with a unique tool (VR) will be a feasible and efficacious way to tackle distress. It is known that only 1% of our MDs have done mindfulness training but nearly 50% are interested in doing so. Therefore, a self-administrable, interactive mindfulness program delivered over VR has great potential to reach clinicians who want to practice a more active form of mindfulness at a time convenient to them. The results of the study will provide preliminary evidence to determine if a take-home VR mindfulness program decreases clinician stress.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2024
CompletedFirst Posted
Study publicly available on registry
February 7, 2024
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
Study Completion
Last participant's last visit for all outcomes
July 31, 2028
March 13, 2026
September 1, 2025
1 year
January 30, 2024
March 11, 2026
Conditions
Outcome Measures
Primary Outcomes (9)
PROMIS - anxiety
PROMIS Short Form - anxiety scale. Scores of 8-40; Higher is a worse outcome.
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the intervention group at 12 and 24 weeks to their baseline.
PROMIS - anxiety
PROMIS Short Form - anxiety scale. Scores of 8-40; Higher is a worse outcome.
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the control group at 12 and 24 weeks to their baseline.
PROMIS - Depression
PROMIS Short Form - Depression scale. Scores of 8-40; Higher is a worse outcome.
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the intervention group at 12 and 24 weeks to their baseline.
PROMIS - Depression
PROMIS Short Form - Depression scale. Scores of 8-40; Higher is a worse outcome.
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the control group at 12 and 24 weeks to their baseline.
Resiliency
Connor-Davidson Resiliency Scale. Scores of 0-40; Higher score is better.
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the intervention group at 12 and 24 weeks to their baseline.
Resiliency
Connor-Davidson Resiliency Scale. Scores of 0-40; Higher score is better.
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the control group at 12 and 24 weeks to their baseline.
Stress scale
Perceived Stress Score. Scores of 0-40; Higher score is worse.
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the intervention group at 12 and 24 weeks to their baseline.
Stress scale
Perceived Stress Score. Scores of 0-40; Higher score is worse.
at baseline, after 12 weeks, then after another 12 weeks. We will compare results of the control group at 12 and 24 weeks to their baseline.
Usability
Usability scale. Scores of 10-50; Higher score is better.
after 12 weeks we will dertermine the usability of the VR intervention in the intervention group
Study Arms (2)
Intervention - VR Mindfulness
EXPERIMENTALThe intervention group will be given the VR headset for their unrestricted use over the 12 week intervention period. The VR headset is exceptionally easy and intuitive to use. Each participant will have the choice of 20 "locations" in which to use the mindfulness-based program. Each of the 20 locations/programs are different. They range in length from 5 minutes (introductory) to 20 minutes.
Control
NO INTERVENTIONThe control arm will not have any intervention. However, at the conclusion of the study, all participants from the Control group will be given the VR intervention
Interventions
Eligibility Criteria
You may qualify if:
- physician or APP employed by the Medical Group
You may not qualify if:
- Not willing to receive 2 texts per week
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UMassMemorial Health Care
Worcester, Massachusetts, 01655-0002, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Bird, MD
University of Massachusetts, Worcester
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Emergency Medicine
Study Record Dates
First Submitted
January 30, 2024
First Posted
February 7, 2024
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
July 31, 2028
Last Updated
March 13, 2026
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share